carbachol has been researched along with Hyperinsulinism in 9 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Hyperinsulinism: A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Insulin resistance is followed by an islet adaptation resulting in a compensating increase in insulin secretion and hyperinsulinemia." | 1.31 | Islet phospholipase A(2) activation is potentiated in insulin resistant mice. ( Ahrén, B; Karlsson, S; Simonsson, E, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lubaczeuski, C | 2 |
| Balbo, SL | 2 |
| Ribeiro, RA | 2 |
| Vettorazzi, JF | 1 |
| Santos-Silva, JC | 1 |
| Carneiro, EM | 2 |
| Bonfleur, ML | 2 |
| Mendes, MC | 1 |
| Maller, AC | 1 |
| Angelini, N | 1 |
| Rafacho, A | 1 |
| Boschero, AC | 1 |
| Bosqueiro, JR | 1 |
| Sørensen, H | 1 |
| Winzell, MS | 1 |
| Brand, CL | 1 |
| Fosgerau, K | 1 |
| Gelling, RW | 1 |
| Nishimura, E | 1 |
| Ahren, B | 2 |
| Zawalich, WS | 2 |
| Kelley, GG | 1 |
| Simonsson, E | 1 |
| Karlsson, S | 1 |
| Rashid, S | 1 |
| Shi, ZQ | 1 |
| Niwa, M | 1 |
| Mathoo, JM | 1 |
| Vandelangeryt, ML | 1 |
| Bilinski, D | 1 |
| Lewis, GF | 1 |
| Vranic, M | 1 |
| Zawalich, KC | 1 |
| Guerre-Millo, M | 1 |
| Rouault, C | 1 |
| Poulain, P | 1 |
| André, J | 1 |
| Poitout, V | 1 |
| Peters, JM | 1 |
| Gonzalez, FJ | 1 |
| Fruchart, JC | 1 |
| Reach, G | 1 |
| Staels, B | 1 |
1 review available for carbachol and Hyperinsulinism
| Article | Year |
|---|---|
The pathogenesis of NIDDM: the role of the pancreatic beta cell.
Topics: Animals; Carbachol; Cholinergic Agents; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucose; Human | 1995 |
8 other studies available for carbachol and Hyperinsulinism
| Article | Year |
|---|---|
Vagotomy ameliorates islet morphofunction and body metabolic homeostasis in MSG-obese rats.
Topics: Animals; Carbachol; Cell Count; Cholesterol; Cholinergic Agonists; Flavoring Agents; Glucose; Homeos | 2015 |
Vagotomy diminishes obesity in cafeteria rats by decreasing cholinergic potentiation of insulin release.
Topics: 1-Methyl-3-isobutylxanthine; Adipose Tissue; Animals; Body Weight; Carbachol; Colforsin; Cyclic AMP; | 2016 |
Involvement of the cholinergic pathway in glucocorticoid-induced hyperinsulinemia in rats.
Topics: Animals; Blood Glucose; Carbachol; Dexamethasone; Drug Tolerance; Glucocorticoids; Glucose; Humans; | 2010 |
Glucagon receptor knockout mice display increased insulin sensitivity and impaired beta-cell function.
Topics: Animals; Arginine; Blood Glucose; Carbachol; Glucagon; Glucose; Glucose Clamp Technique; Glucose Tol | 2006 |
Islet phospholipase A(2) activation is potentiated in insulin resistant mice.
Topics: Animals; Arachidonic Acid; Blood Glucose; Body Weight; Carbachol; Diabetes Mellitus, Type 2; Dietary | 2000 |
Beta-blockade, but not normoglycemia or hyperinsulinemia, markedly diminishes stress-induced hyperglycemia in diabetic dogs.
Topics: Adrenergic beta-Antagonists; Animals; Blood Glucose; Carbachol; Diabetes Mellitus, Experimental; Dog | 2000 |
A link between insulin resistance and hyperinsulinemia: inhibitors of phosphatidylinositol 3-kinase augment glucose-induced insulin secretion from islets of lean, but not obese, rats.
Topics: Androstadienes; Animals; Calcium; Carbachol; Cell Separation; Enzyme Inhibitors; Glucose; Hyperinsul | 2000 |
PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Blood Glucose; Carbachol; Dietary Fats; Drug Synergism; Fastin | 2001 |